PRESS RELEASE published on 01/26/2026 at 18:00, 2 months 9 days ago Déclaration des transactions sur actions propres SCBSM déclare les rachats d'actions propres conformément au règlement Abus de marché (MAR). Cette foncière cotée sur Euronext Paris possède un patrimoine immobilier de 468 M€, principalement à Paris QCA. Pour plus d'informations, visitez www.scbsm.fr Euronext Paris Rachats D'actions Patrimoine Immobilier SCBSM Foncière Cotée
PRESS RELEASE published on 01/26/2026 at 17:59, 2 months 9 days ago PoPP draft specifications support seamless continuation of Redcare Pharmacy’s digital e-prescription journey. Germany's gematik publishes PoPP draft specifications for digital e-prescription journey by Redcare Pharmacy. Enhances security, flexibility, and accessibility to healthcare services Redcare Pharmacy Healthcare Services Gematik Digital E-prescription PoPP
PRESS RELEASE published on 01/26/2026 at 17:45, 2 months 9 days ago Dr. Christian Schlögel nominated as new member of the Board of Directors Dr. Christian Schlögel nominated as new member of the Board of Directors at SKAN Group AG, bringing 30 years of leadership experience in software, digital transformation, and AI Board Of Directors Digital Transformation Leadership SKAN Group AG Dr. Christian Schlögel
REGULATED PRESS RELEASE published on 01/26/2026 at 17:45, 2 months 9 days ago Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments Gimv verlagert den Fokus auf strategische Ziele und stellt Aktivitäten für neue Life-Sciences-Investitionen ein Gimv Life Sciences Wachstum Investitionen Strategische Ziele
PRESS RELEASE published on 01/26/2026 at 17:45, 2 months 9 days ago Chiffre d'affaires annuel à 225,6 m EUR (+10,2% à périmètre et taux de change constants) LUMIBIRD réalise un chiffre d'affaires annuel de 225,6m€ en 2025, confirmant une croissance de +8,9% (+10,2% à périmètre et taux de change constants) et une rentabilité accrue Chiffre D'affaires Croissance Rentabilité EBITDA LUMIBIRD
PRESS RELEASE published on 01/26/2026 at 17:45, 2 months 9 days ago Lumibird: FY revenue of EUR 225.6 million (+10.2% at constant scope and exchange rates) LUMIBIRD Group achieves FY revenue of €225.6 million, up 10.2% at constant scope and exchange rates. Photonics division shows strong growth. Medical division sales stable reflecting resilient activity. 2025 EBITDA margin expected over 19% Revenue Growth Photonics LUMIBIRD Medical Division 2025 Financial Results
REGULATED PRESS RELEASE published on 01/26/2026 at 17:45, 2 months 9 days ago Gimv verhoogt focus op strategische doelstellingen en discontinueert activiteiten voor nieuwe Life Sciences investeringen Gimv verhoogt focus op strategische doelstellingen en stopt met Life Sciences investeringen. Raad van bestuur richt zich op Anchor, Consumer, Healthcare, Smart Industries en Sustainable Cities voor groei Gimv Life Sciences Groei Investeringen Strategische Doelstellingen
REGULATED PRESS RELEASE published on 01/26/2026 at 17:45, 2 months 9 days ago Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments Gimv increases focus on strategic objectives by discontinuing new Life Sciences investments to concentrate on Consumer, Healthcare, Smart Industries, and Sustainable Cities sectors. Board focuses on digital transition growth opportunities Gimv Healthcare Strategic Objectives Smart Industries Consumer
REGULATED PRESS RELEASE published on 01/26/2026 at 17:45, 2 months 9 days ago Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments Gimv focuses on strategic objectives, discontinues new Life Sciences investments to concentrate on Consumer, Healthcare, Smart Industries, Sustainable Cities Gimv Healthcare Investments Strategic Objectives Consumer
PRESS RELEASE published on 01/26/2026 at 17:40, 2 months 9 days ago VALBIOTIS SA: Valbiotis launches an exclusive commercial benefit for its shareholders: a 20% discount on ValbiotisPRO® and ValbiotisPLUS® ranges Valbiotis launches a 20% discount on ValbiotisPRO® and ValbiotisPLUS® ranges exclusively for its shareholders, strengthening the link with them and rewarding their commitment Shareholders Valbiotis Discount Health Supplements
Published on 04/02/2026 at 22:00, 1 day 20 hours ago Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 2 days ago Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 2 days 3 hours ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 2 days 4 hours ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 2 days 4 hours ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/04/2026 at 10:07, 8 hours 36 minutes ago Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Published on 04/04/2026 at 02:05, 16 hours 37 minutes ago Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 1 day ago IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 1 day ago IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 1 day ago Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems
Published on 04/03/2026 at 18:46, 23 hours 56 minutes ago Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 23 hours 56 minutes ago Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 1 day ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 1 day ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 1 day ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026